Crescent Capital Group Closes Second CLO Equity Fund at $232 Million
The fund doubles the size of its 2018 predecessor as institutional investors including global insurance companies and pension funds back the strategy's next vintage.
LOS ANGELES, Aug. 27, 2026. Crescent Capital Group LP, one of the leading alternative credit investment firms, announced the final close of its second captive collateralized loan obligation equity fund, Crescent CLO Equity Funding II, with $232 million in commitments. The fund doubled the size of its predecessor, Crescent CLO Equity Funding I, which closed in 2018 with $103 million in commitments.
Sophisticated institutional investors, including global insurance companies and pension funds, participated in the close. CLO Equity Funding II will focus primarily on investments in control positions of Crescent CLOs, while also providing flexibility to opportunistically invest in the debt of Crescent CLOs and third-party CLOs. Crescent's CLO platform dates back to 1993, making it one of the longest-tenured CLO managers in the market.
"Despite a competitive fundraising environment, this close reflects the continued evolution of our CLO issuance strategy and the growing conviction we are seeing from investors across the institutional landscape," said Nilesh Mandhare, Managing Director, Head and Portfolio Manager for Crescent's CLO issuance strategy.
"CLOs are an increasingly important component of our broader credit platform, bringing together our investment expertise, structuring capabilities, and longstanding institutional relationships," said John Fekete, Managing Director and Head of Tradeable Credit at Crescent.
Crescent is a global credit investment manager with $53 billion of assets under management as of June 30, 2026, and is part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life.